Current Neurology and Neuroscience Reports

, Volume 8, Issue 2, pp 87–93

Idiopathic intracranial hypertension (Pseudotumor cerebri)

Article

Abstract

Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown cause. Patients present with daily headache, pulse-synchronous tinnitus, transient visual obscurations, papilledema with its associated visual loss, and diplopia from sixth nerve paresis. Many disease associations have been alleged, but few besides obesity, hypervitaminosis A and related compounds, steroid withdrawal, and female gender have been proven. Although absorption of cerebrospinal fluid (CSF) occurs through arachnoid granulations and extracranial lymphatics, outflow resistance is increased in IIH; therefore, intracranial pressure must increase for CSF to be absorbed. The mainstays of medical treatment are a reduced-sodium weight-reduction program and acetazolamide. If patients fail medical therapy, surgical procedures, most commonly optic nerve sheath fenestration and CSF shunting, are employed. The main morbidity of IIH is visual loss. This is present in most patients and can usually be reversed if recognized early in the course of the disease and treated. Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown cause. Patients present with daily headache, pulse-synchronous tinnitus, transient visual obscurations, papilledema with its associated visual loss, and diplopia from sixth nerve paresis. Many disease associations have been alleged, but few besides obesity, hypervitaminosis A and related compounds, steroid withdrawal, and female gender have been proven. Although absorption of cerebrospinal fluid (CSF) occurs through arachnoid granulations and extracranial lymphatics, outflow resistance is increased in IIH; therefore, intracranial pressure must increase for CSF to be absorbed. The mainstays of medical treatment are a reduced-sodium weight-reduction program and acetazolamide. If patients fail medical therapy, surgical procedures, most commonly optic nerve sheath fenestration and CSF shunting, are employed. The main morbidity of IIH is visual loss. This is present in most patients and can usually be reversed if recognized early in the course of the disease and treated.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988, 45:875–877.PubMedGoogle Scholar
  2. 2.
    Garrett J, Corbett JJ, Braswell RA, Santiago M: The increasing incidence of IIH. The effect of obesity on frequency of occurrence in Mississippi. Ann Neurol 2004, 56(Suppl 8):S69.Google Scholar
  3. 3.
    Daniels AB, Liu GT, Volpe NJ, et al.: Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007, 143:635–641.PubMedCrossRefGoogle Scholar
  4. 4.
    Balcer LJ, Liu GT, Forman S, et al.: Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999, 52:870–872.PubMedGoogle Scholar
  5. 5.
    Digre KB, Corbett JJ: Pseudotumor cerebri in men. Arch Neurol 1988, 45:866–872.PubMedGoogle Scholar
  6. 6.
    Ireland B, Corbett JJ, Wallace RB: The search for causes of idiopathic intracranial hypertension. A preliminary casecontrol study. Arch Neurol 1990, 47:315–320.PubMedGoogle Scholar
  7. 7.
    Giuseffi V, Wall M, Siegel PZ, Rojas PB: Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991, 41:239–244.PubMedGoogle Scholar
  8. 8.
    Boulton M, Armstrong D, Flessner M, et al.: Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics. Am J Physiol 1998, 275(3 Pt 2):889–896.Google Scholar
  9. 9.
    Koh L, Nagra G, Johnston M: Properties of the lymphatic cerebrospinal fluid transport system in the rat: impact of elevated intracranial pressure. J Vasc Res 2007, 44:423–432.PubMedCrossRefGoogle Scholar
  10. 10.
    Sahs AL, Joynt RJ: Brain swelling of unknown cause. Neurology 1956, 6:791–803.Google Scholar
  11. 11.
    Wall M, Dollar JD, Sadun AA, Kardon R: Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema. Arch Neurol 1995, 52:141–145.PubMedGoogle Scholar
  12. 12.
    Wall M: The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990, 10:331–335.PubMedCrossRefGoogle Scholar
  13. 13.
    Friedman DI, Rausch EA: Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002, 58:1551–1553.PubMedGoogle Scholar
  14. 14.
    Meador KJ, Swift TR: Tinnitus from intracranial hypertension. Neurology 1984, 34:1258–1261.PubMedGoogle Scholar
  15. 15.
    Farb RI, Vanek I, Scott JN, et al.: Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003, 60:1418–1424.PubMedGoogle Scholar
  16. 16.
    Wall M, White WN: Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998, 39:134–142.PubMedGoogle Scholar
  17. 17.
    Wall M, George D: Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991, 114:155–180.PubMedCrossRefGoogle Scholar
  18. 18.
    Smith JL: Whence pseudotumor cerebri? J Clin Neuroophthalmol 1985, 5:55–56.PubMedGoogle Scholar
  19. 19.
    Neville L, Egan RA: Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005, 40:775–777.PubMedGoogle Scholar
  20. 20.
    Whiteley W, Al Shahi R, Warlow CP, et al.: CSF opening pressure: reference interval and the effect of body mass index. Neurology 2006, 67:1690–1691.PubMedCrossRefGoogle Scholar
  21. 21.
    Bono F, Quattrone A: CSF opening pressure: reference interval and the effect of body mass index. Neurology 2007, 68:1439–1440.PubMedCrossRefGoogle Scholar
  22. 22.
    Corbett JJ, Mehta MP: Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983, 33:1386–1388.PubMedGoogle Scholar
  23. 23.
    Bono F, Lupo MR, Serra P, et al.: Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002, 59:1641–1643.PubMedGoogle Scholar
  24. 24.
    Yeh YC, Tang HF, Fang IM: Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Jpn J Ophthalmol 2006, 50:295–296.PubMedCrossRefGoogle Scholar
  25. 25.
    Winn BJ, Liao YJ, Horton JC: Intracranial pressure returns to normal about a month after stopping tetracycline antibiotics. Arch Ophthalmol 2007, 125:1137–1138.PubMedCrossRefGoogle Scholar
  26. 26.
    Ang ER, Zimmerman JC, Malkin E: Pseudotumor cerebri secondary to minocycline intake. J Am Board Fam Pract 2002, 15:229–233.PubMedGoogle Scholar
  27. 27.
    Wall M: Papilledema and idiopathic intracranial hypertension (pseudotumor cerebri). In Neurological Therapeutics Principles and Practice. Edited by Noseworthy JH. Abingdon, UK: Informa Healthcare; 2006:1955–1968.Google Scholar
  28. 28.
    Newborg B: Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974, 133:802–807.PubMedCrossRefGoogle Scholar
  29. 29.
    Johnson LN, Krohel GB, Madsen RW, March GA Jr: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998, 105:2313–2317.PubMedCrossRefGoogle Scholar
  30. 30.
    Kupersmith MJ, Gamell L, Turbin R, et al.: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998, 50:1094–1098.PubMedGoogle Scholar
  31. 31.
    Wong R, Madill SA, Pandey P, Riordan-Eva P: Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007, 7:15.PubMedCrossRefGoogle Scholar
  32. 32.
    Sugerman HJ, Felton WL III, Sismanis A, et al.: Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999, 229:634–640.PubMedCrossRefGoogle Scholar
  33. 33.
    Johnston I, Paterson A: Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974, 97:301–312.PubMedCrossRefGoogle Scholar
  34. 34.
    Scoffings DJ, Pickard JD, Higgins JN: Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2007, 78:911–912.PubMedCrossRefGoogle Scholar
  35. 35.
    McCarthy KD, Reed DJ: The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974, 189:194–201.PubMedGoogle Scholar
  36. 36.
    Gucer G, Vierenstein L: Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg 1978, 49:256–263.PubMedGoogle Scholar
  37. 37.
    Tomsak RL, Niffenegger AS, Remler BF: Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuro-ophthalmol 1988, 8:93–98.Google Scholar
  38. 38.
    Celebisoy N, Gokcay F, Sirin H, Akyurekli O: Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007, 116:322–327.PubMedCrossRefGoogle Scholar
  39. 39.
    Zimran A, Beutler E: Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts? Am J Ophthalmol 1987, 104:654–658.PubMedGoogle Scholar
  40. 40.
    Shah VA, Fung S, Shahbaz R, et al.: Idiopathic intracranial hypertension. Ophthalmology 2007, 114:617.PubMedCrossRefGoogle Scholar
  41. 41.
    Corbett JJ: The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983, 10:221–229.PubMedGoogle Scholar
  42. 42.
    Pollay M, Fullenwider C, Roberts PA, Stevens FA: Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983, 59:945–950.PubMedGoogle Scholar
  43. 43.
    Kessler LA, Novelli PM, Reigel DH: Surgical treatment of benign intracranial hypertension-subtemporal decompression revisited. Surg Neurol 1998, 50:73–76.PubMedCrossRefGoogle Scholar
  44. 44.
    Goh KY, Schatz NJ, Glaser JS: Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 1997, 17:86–91.PubMedGoogle Scholar
  45. 45.
    Acheson JF, Green WT, Sanders MD: Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatr 1994, 57:1426–1429.PubMedGoogle Scholar
  46. 46.
    Sergott RC, Savino PJ, Bosley TM: Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1391–1397.Google Scholar
  47. 47.
    Corbett JJ, Nerad JA, Tse D, Anderson RL: Optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol 1988, 106:1391–1397.PubMedGoogle Scholar
  48. 48.
    Plotnik JL, Kosmorsky GS: Operative complications of optic nerve sheath decompression. Ophthalmology 1993, 100:683–690.PubMedGoogle Scholar
  49. 49.
    Brourman ND, Spoor TC, Ramocki JM: Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1378–1383.PubMedGoogle Scholar
  50. 50.
    Chandrasekaran S, McCluskey P, Minassian D, Assaad N: Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Exp Ophthalmol 2006, 34:661–665.CrossRefGoogle Scholar
  51. 51.
    Curry WT Jr, Butler WE, Barker FG: Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005, 57:97–108.PubMedCrossRefGoogle Scholar
  52. 52.
    Eggenberger ER, Miller NR, Vitale S: Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996, 46:1524–1530.PubMedGoogle Scholar
  53. 53.
    Rosenberg M, Smith C, Beck R: The efficacy of shunting procedures in pseudotumor cerebri. Neurology 1989, 39:209.Google Scholar
  54. 54.
    Burgett RA, Purvin VA, Kawasaki A: Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997, 49:734–739.PubMedGoogle Scholar
  55. 55.
    Johnston I, Besser M, Morgan MK: Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988, 69:195–202.PubMedCrossRefGoogle Scholar
  56. 56.
    McGirt MJ, Woodworth G, Thomas G, et al.: Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004, 101:627–632.PubMedGoogle Scholar
  57. 57.
    King JO, Mitchell PJ, Thomson KR, Tress BM: Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002, 58:26–30.PubMedGoogle Scholar
  58. 58.
    Friedman DI: Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006, 26:61–64.PubMedGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.University of Iowa Carver College of Medicine, Veterans Administration HospitalIowa CityUSA

Personalised recommendations